Medicare Rx Price Controls Are Serious Threat In 106th Congress - Holcombe
Executive Summary
The pharmaceutical industry should be prepared for serious legislative debate in Congress over proposals to address the prices paid by seniors for medicine, former House Commerce Committee Democratic Senior Health Policy Advisor Kay Holcombe told a Drug Information Association conference on drug pricing in Washington, D.C. April 15.